IQ, OQ & PQ Services

Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) are the three formal validation stages required in GxP-regulated industries. IQ verifies that the monitoring system is installed according to specifications and design intent. OQ confirms the system operates within defined parameters under controlled test conditions. PQ proves the system performs reliably and consistently under actual real-world operating conditions — providing the documented evidence regulators require before a monitoring system can be used in a regulated process.

IQ/OQ/PQ validation is required for monitoring systems used in GxP, GDP, GMP, and FDA 21 CFR Part 11-regulated environments. This includes pharmaceutical manufacturing and warehousing, clinical trial facilities, blood banks, biorepositories, and any GMP-controlled laboratory or production area where electronic monitoring records are part of the quality system.

Yes. Seemoto delivers a complete validation package: Validation Master Plan, IQ/OQ/PQ test protocols, executed protocol reports, deviation records, risk assessment, and the final validation summary report. All documents are formatted to meet typical regulatory authority expectations and can be submitted as part of an inspection dossier.

Yes. Seemoto's validation specialists can attend regulatory inspections and audits to support quality teams, answer technical questions about the monitoring system, and provide supplementary evidence. On-site audit support is available as an add-on to the standard validation package.

Annual revalidation is the standard recommendation for GMP and GDP environments. Revalidation is also triggered by changes to the monitoring system, hardware replacements, significant facility alterations, or as directed by your quality management system (QMS) change control procedures. Seemoto offers revalidation service contracts to keep your system continuously compliant.

Yes. Seemoto provides a readiness assessment and compliance documentation package specifically for FDA 21 CFR Part 11 requirements covering electronic records, audit trails, and electronic signatures. This is essential for pharmaceutical companies and contract manufacturers subject to FDA oversight.